Platform Trial In COVID-19 Vaccine BOOsting (PICOBOO) - A single blinded, phase IV, adaptive randomised trial to evaluate the immunogenicity of COVID-19 booster vaccines in adults
Latest Information Update: 20 May 2025
At a glance
- Drugs AZD 1222 (Primary) ; COVID-19 vaccine adjuvanted Novavax (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Acronyms PICOBOO
Most Recent Events
- 15 Mar 2022 New trial record